We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$110B
AUM Growth
+$11.3B
(+11%)
Cap. Flow
+$8.89B
Cap. Flow
% of AUM
8.09%
Top 10 Holdings %
Top 10 Hldgs %
35.27%
Holding
3,643
New
809
Increased
972
Reduced
1,047
Closed
744
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.35B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.85B |
| 3 |
Eli Lilly
LLY
|
+$999M |
| 4 |
Coca-Cola
KO
|
+$685M |
| 5 |
Broadcom
AVGO
|
+$616M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
Netflix
NFLX
|
+$678M |
| 4 |
Boston Scientific
BSX
|
+$671M |
| 5 |
Cencora
COR
|
+$627M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Consumer Discretionary | 12.77% |
| 3 | Healthcare | 10.45% |
| 4 | Financials | 7.74% |
| 5 | Communication Services | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Coastal Financial
CCB
$793M
| $367K | ﹤0.01% |
+3,200
| New | +$349K |
|
|
LKFT
2352
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.88B
| $366K | ﹤0.01% |
11,200
-27,260
| -71% | -$880K |
|
2353
Cirrus Logic
CRUS
$6.11B
| $366K | ﹤0.01% |
3,086
-44,072
| -93% | -$5.43M |
|
2354
iShares MSCI Hong Kong ETF
EWH
$1.21B
| $366K | ﹤0.01% |
17,200
-1,035
| -6% | -$22.5K |
|
|
AIFC
2355
AI Financial Corp
AIFC
$58.7M
| $364K | ﹤0.01% |
+330,632
| New | +$637K |
|
|
INGM
2356
Ingram Micro Holding
INGM
$6.37B
| $362K | ﹤0.01% |
16,982
-277,677
| -94% | -$6.02M |
|
|
CNTB
2357
Connect Biopharma Holdings
CNTB
$141M
| $362K | ﹤0.01% |
128,368
+70,337
| +121% | +$150K |
|
2358
Sana Biotechnology
SANA
$1.05B
| $361K | ﹤0.01% |
+88,788
| New | +$398K |
|
|
AVDL
2359
DELISTED
Avadel Pharmaceuticals
AVDL
| $360K | ﹤0.01% |
16,686
-509,019
| -97% | -$9.88M |
|
|
DRUG
2360
Bright Minds Biosciences
DRUG
$787M
| $359K | ﹤0.01% |
+4,600
| New | +$307K |
|
2361
Equity Lifestyle Properties
ELS
$12.4B
| $358K | ﹤0.01% |
+5,900
| New | +$365K |
|
|
SEM
2362
DELISTED
Select Medical
SEM
| $356K | ﹤0.01% |
+24,000
| New | +$339K |
|
2363
CALL
Blackstone
BX
$118B
| $355K | ﹤0.01% |
2,300
-700
| -23% | -$106K |
|
2364
CVRx
CVRX
$69M
| $354K | ﹤0.01% |
49,827
+33,677
| +209% | +$307K |
|
2365
CALL
lululemon athletica
LULU
$14.3B
| $353K | ﹤0.01% |
1,700
-2,100
| -55% | -$380K |
|
2366
Mine Safety
MSA
$7.44B
| $352K | ﹤0.01% |
2,200
-1,896
| -46% | -$309K |
|
2367
Franklin FTSE South Korea ETF
FLKR
$1.45B
| $352K | ﹤0.01% |
+10,989
| New | +$335K |
|
|
TLX
2368
Telix Pharmaceuticals
TLX
$4.07B
| $349K | ﹤0.01% |
46,658
-1,915
| -4% | -$18.4K |
|
2369
TD Synnex
SNX
$20.3B
| $349K | ﹤0.01% |
2,324
-400,430
| -99% | -$61.4M |
|
2370
Global Industrial
GIC
$1.5B
| $349K | ﹤0.01% |
11,946
-42,589
| -78% | -$1.3M |
|
2371
PUT
iShares Expanded Tech-Software Sector ETF
IGV
$14.9B
| $349K | ﹤0.01% |
3,300
-1,100
| -25% | -$121K |
|
|
NUAI
2372
New Era Energy & Digital Inc
NUAI
$530M
| $347K | ﹤0.01% |
+118,503
| New | +$481K |
|
|
ACOG
2373
Alpha Cognition
ACOG
$193M
| $346K | ﹤0.01% |
53,203
-19,009
| -26% | -$120K |
|
2374
MakeMyTrip
MMYT
$5.78B
| $345K | ﹤0.01% |
4,204
-1,368,867
| -100% | -$112M |
|
2375
Qualys
QLYS
$6.51B
| $344K | ﹤0.01% |
2,591
-3,831
| -60% | -$527K |
|
Similar funds
Marshall Wace's Q4 2025 Portfolio in Review
As of Q4 2025, Marshall Wace held 3,643 positions worth $110B, up 11% from $98.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $8.89B of net new capital in Q4 2025, opening 809 new positions and adding to 972 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $1.38B trimmed.
- Marshall Wace's largest Q4 2025 buy was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.35B increase.
- Marshall Wace's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.38B.
- Marshall Wace fully exited Ares Management in Q4 2025, selling an estimated $146M.
- Marshall Wace's ten largest holdings make up 35% of its $110B portfolio in Q4 2025.
- Marshall Wace opened 809 new positions and closed 744 in Q4 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $110B.
Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.